Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis

Hepatology International

Volumn 8, Issue 4, 2014, Pages 588-594

  Karagiannakis, Dimitrios S ^a   Vlachogiannakos, Jiannis ^a   Anastasiadis, Georgios ^a   Vafiadis Zouboulis, Irini ^a   Ladas, Spiros D ^a  

^a LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Cardiomyopathy; Cirrhosis; Diastolic dysfunction; Survival

Indexed keywords

ALBUMIN; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CHILD PUGH SCORE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE COURSE; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HUMAN; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MEDICAL SOCIETY; MELD SCORE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTION; PROGNOSIS; QT PROLONGATION; REFERENCE VALUE; SCORING SYSTEM; TISSUE DOPPLER IMAGING;

EID: 84919842630     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-014-9544-6     Document Type: Article

References (30)

1. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rode’s J. Peripheral artery vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;5:1151–1157
2. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 2006;43:S121–S131
3. Salermo F, Cazzaniga M, Gobbo G. Pharmacological treatment of hepatorenal syndrome: a note of optimism. J Hepatol 2007;47:729–731
4. Moller S, Henriksen JH. The systemic circulation in cirrhosis. In Gines P, Arroyo V, Rodes J, Schrier RW, editors. Ascites and Renal Dysfunction in Liver Disease. 2nd ed. Malden: Blackwell; 2005. 139–155
5. Krag A, Bendtsen F, Burroughs AK, Moller S. The cardiorenal link in advanced cirrhosis. Med Hypotheses 2012;79:53–55
6. Timoh T, Protano MA, Wagman G, Bloom M, Vittorio TJ. A perspective on cirrhotic cardiomyopathy. Transplant Proc 2011;43:1649–1653
7. Moller S, Hove JD, Dixen U, Bendtsen F. New insights into cirrhotic cardiomyopathy. Int J Cardiol 2013;167:1101–1108
8. Bernardi M, Maggioli C, Dibra V, Zaccherini G. QT interval prolongation in liver cirrhosis: innocent bystander or serious threat? Expert Rev Gastroenterol Hepatol 2012;6:57–66
9. Wiese S, Hove JD, Bendtsen F, Moller S. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2013;11:177–186
10. Pozzi M, Redaelli E, Ratti L, Poli G, Guidi C, Milanese M, et al. Time-course of diastolic dysfunction in different stages of chronic HCV related liver diseases. Minerva Gastroenterol Dietol 2005;51:179–186
11. Guilo P, Mansourati J, Maheu B, Etienne Y, Provost K, Simon O, et al. Long-term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence. Am J Cardiol 1997;79(9):1276–1278
12. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107–133
13. Klein AL, Burstow DJ, Talik AJ, Zachariak PK, Bailey KR, Seward JB. Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons. Mayo Clin Proc 1994;69:212–224
14. Kazankov K, Holland-Fischer P, Andersen NH, Torp P, Sloth E, Aagaard NK, et al. Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging. Liver Int 2011;31:534–540
15. Sampaio F, Pimenta J, Bettencourt N, Fontes‐Carvalho R, Silva AP, Valente J, et al. Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study. Liver int 2013;33:1158–1165
16. Lee RF, Glenn TK, Lee SS. Cardiac dysfunction in cirrhosis. Best Pract Res Clin Gastroenterol 2007;21:125–140
17. Mandell MS, Lindenfeld J, Tsou MY, Zimmerman M. Cardiac evaluation of liver transplant candidates. World J Gastroenterol 2008;14:3445–3451
18. Moller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J 2013;34:2804–2811
19. Cazzaniga M, Salerno F, Pagnozzi G, Dionigi E, Visentin S, Cirello I, et al. Diastolic dysfunction is associated with poor survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt. Gut 2007;56:869–875
20. Rabie RN, Cazzaniga M, Salerno F, Wong F. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 2009;104:2458–2466
21. Ripoll C, Catalina MV, Yotti R, Olmedilla L, Pérez-Peña J, Iacono O, et al. Cardiac dysfunction during liver transplantation: incidence and preoperative predictors. Transplantation 2008;85:1766–1772
22. Holt EW, Woo G, Trilesskaya M, Haeusslein EA, Shaw RE, Frederick RT. Diastolic dysfunction defined by E/A ratio < 1 on 2-D echo is an independent predictor of liver transplantation or death in patient with cirrhosis. J Hepatol 2011;54:S245–S246
23. Ruiz-del-Arbol L, Achecar L, Serradilla R, Rodríguez‐Gandía MÁ, Rivero M, Garrido E, et al. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension and I normal creatinine. Hepatology 2013;58:1732–1741
24. Nazar A, Guevara M, Sitges M, Terra C, Solà E, Guigou C, et al. Left ventricular function assessed by echocardiography in cirrhosis: Relationship to systemic hemodynamics and renal dysfunction. J Hepatol 2013;58:51–57
25. Merli M, Calicchia A, Ruffa A, Pellicori P, Riggio O, Giusto M, et al. Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease. Euro J Int Med 2013;24:172–176
26. Alexopoulou A, Papatheodoridis G, Pouriki S, Chrysohoou C, Raftopoulos L, Stefanadis C, et al. Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis. Transpl Int 2012;25:1174–1181
27. Henriksen JH, Goetze JP, Fuglsang S, Christensen E, Bendtsen F, Moller S. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut 2003;52:1511–1157
28. Pimenta J, Paulo C, Gomes A, Silva S, Rocha-Goncalves F, Bettencourt P. B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis. Liver Int 2010;30:1059–1066
29. Bal JS, Thuluvath PJ. Prolongation of QTc inteval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver int 2003;23:243–248
30. Trevisani F, Di Micoli A, Zambruni A, Biselli M, Santi V, Erroi V, et al. QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. Liver Int 2012;32:1510–1515